MAZE
#2149
Maze Therapeutics, Inc. - Common Stock
26.5 7 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-4.08%
Variazione Mensile
+6.71%
Variazione di 6 mesi
-3.94%
Variazione Annuale
-40.99%
Chiusura Precedente
27.7 0
Open
27.5 4
Minimo
26.5 7
Massimo
28.2 4
Financials
2026
Current report, 13 Aug 2026
Maze Therapeutics, Inc. current report, 13 August 2026
8-K
Current report, Q3 FY2026
Maze Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Maze Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Maze Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K